AbCellera Biologics Inc.
|
-0.51 USD
|
623.529%
|
Alkermes plc
|
2.14 USD
|
-24.766%
|
Agenus Inc.
|
-13.75 USD
|
119.418%
|
Aptorum Group Limited
|
-0.62 USD
|
530.645%
|
Ardelyx, Inc.
|
-0.30 USD
|
990.0%
|
Dyadic International, Inc.
|
-0.24 USD
|
1212.5%
|
Eton Pharmaceuticals, Inc.
|
-0.04 USD
|
7415.068%
|
Lantern Pharma Inc.
|
-1.47 USD
|
281.633%
|
Inhibikase Therapeutics, Inc.
|
-3.57 USD
|
174.79%
|
Novavax, Inc.
|
-5.41 USD
|
149.353%
|
Janux Therapeutics, Inc.
|
-1.32 USD
|
302.273%
|
Pyxis Oncology, Inc.
|
-1.85 USD
|
244.324%
|
TransCode Therapeutics, Inc.
|
-103.61 USD
|
102.577%
|
Ocuphire Pharma, Inc.
|
-0.46 USD
|
680.435%
|
Outlook Therapeutics, Inc.
|
-4.72 USD
|
156.568%
|
Madrigal Pharmaceuticals, Inc.
|
-19.99 USD
|
113.357%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
313.6%
|
SELLAS Life Sciences Group, Inc.
|
-1.34 USD
|
299.254%
|
Syros Pharmaceuticals, Inc.
|
-5.81 USD
|
145.955%
|
Barinthus Biotherapeutics plc
|
-1.91 USD
|
239.791%
|
Windtree Therapeutics, Inc.
|
-92.23 USD
|
102.895%
|
Xeris Biopharma Holdings, Inc.
|
-0.45 USD
|
693.333%
|
Clearside Biomedical, Inc.
|
-0.53 USD
|
603.774%
|
C4 Therapeutics, Inc.
|
-2.67 USD
|
200.0%
|
Alnylam Pharmaceuticals, Inc.
|
-3.52 USD
|
175.852%
|
AlloVir, Inc.
|
-1.83 USD
|
245.902%
|
Arrowhead Pharmaceuticals, Inc.
|
-1.91 USD
|
239.791%
|
VYNE Therapeutics Inc.
|
-2.77 USD
|
196.39%
|
Bicycle Therapeutics plc
|
-5.08 USD
|
152.559%
|
BioXcel Therapeutics, Inc.
|
-6.15 USD
|
143.415%
|
ChromaDex Corporation
|
-0.07 USD
|
4151.593%
|
Chimerix, Inc.
|
-0.93 USD
|
387.097%
|
Corbus Pharmaceuticals Holdings, Inc.
|
-10.31 USD
|
125.897%
|
Caribou Biosciences, Inc.
|
-1.38 USD
|
293.478%
|
CRISPR Therapeutics AG
|
-1.94 USD
|
237.629%
|
Precision BioSciences, Inc.
|
-15.96 USD
|
116.729%
|
Fate Therapeutics, Inc.
|
-1.64 USD
|
262.805%
|
Fortress Biotech, Inc.
|
-8.47 USD
|
131.523%
|
Fortress Biotech, Inc.
|
-8.47 USD
|
131.523%
|
HOOKIPA Pharma Inc.
|
-8.63 USD
|
130.939%
|
ImmuCell Corporation
|
-0.75 USD
|
456.0%
|
IDEAYA Biosciences, Inc.
|
-1.96 USD
|
236.224%
|
Immix Biopharma, Inc.
|
-0.89 USD
|
400.0%
|
Innoviva, Inc.
|
2.92 USD
|
8.562%
|
IO Biotech, Inc.
|
-1.98 USD
|
234.848%
|
Jaguar Health, Inc.
|
-107.42 USD
|
102.486%
|
Keros Therapeutics, Inc.
|
-5.20 USD
|
151.346%
|
Ligand Pharmaceuticals Incorporated
|
3.02 USD
|
11.589%
|
ContextLogic Inc.
|
-13.36 USD
|
119.985%
|
MiMedx Group, Inc.
|
0.48 USD
|
-456.25%
|
MEI Pharma, Inc.
|
2.67 USD
|
0.0%
|
NextCure, Inc.
|
-2.25 USD
|
218.667%
|
Onconetix, Inc.
|
-2.19 USD
|
221.918%
|
Oncternal Therapeutics, Inc.
|
-13.43 USD
|
119.881%
|
Opthea Limited
|
-0.35 USD
|
862.857%
|
Psyence Biomedical Ltd.
|
-7.85 USD
|
134.013%
|
Vaxcyte, Inc.
|
-4.14 USD
|
164.493%
|
PDS Biotechnology Corporation
|
-1.39 USD
|
292.086%
|
Precigen, Inc.
|
-0.39 USD
|
784.615%
|
Pharming Group N.V.
|
-0.16 USD
|
1768.75%
|
Phathom Pharmaceuticals, Inc.
|
-3.93 USD
|
167.939%
|
Pieris Pharmaceuticals, Inc.
|
-21.80 USD
|
112.248%
|
PureTech Health plc
|
-2.38 USD
|
212.185%
|
Rigel Pharmaceuticals, Inc.
|
-1.44 USD
|
285.417%
|
Avidity Biosciences, Inc.
|
-2.91 USD
|
191.753%
|
Reviva Pharmaceuticals Holdings, Inc.
|
-1.25 USD
|
313.6%
|
Sangamo Therapeutics, Inc.
|
-1.48 USD
|
280.405%
|
Sol-Gel Technologies Ltd.
|
-1.01 USD
|
364.356%
|
Acelyrin, Inc.
|
-5.43 USD
|
149.171%
|
Salarius Pharmaceuticals, Inc.
|
-0.00 USD
|
70363.158%
|
Summit Therapeutics Inc.
|
-0.99 USD
|
369.697%
|
Sensei Biotherapeutics, Inc.
|
-1.22 USD
|
318.852%
|
Senti Biosciences, Inc.
|
-16.01 USD
|
116.677%
|
Stoke Therapeutics, Inc.
|
-2.38 USD
|
212.185%
|
Elevation Oncology, Inc.
|
-1.34 USD
|
299.254%
|
Alaunos Therapeutics, Inc.
|
-21.97 USD
|
112.153%
|
Telomir Pharmaceuticals, Inc. Common Stock
|
-0.44 USD
|
706.818%
|
Entrada Therapeutics, Inc.
|
-0.20 USD
|
1435.0%
|
VistaGen Therapeutics, Inc.
|
-1.52 USD
|
275.658%
|
Kintara Therapeutics, Inc.
|
-3.23 USD
|
182.663%
|
Wave Life Sciences Ltd.
|
-0.54 USD
|
594.444%
|
Seer, Inc.
|
-1.35 USD
|
297.778%
|
Verrica Pharmaceuticals Inc.
|
-1.48 USD
|
280.405%
|
Aadi Bioscience, Inc.
|
-2.44 USD
|
209.426%
|
ESSA Pharma Inc.
|
-0.60 USD
|
545.0%
|
GlycoMimetics, Inc.
|
-0.58 USD
|
560.345%
|
GT Biopharma, Inc.
|
-5.64 USD
|
147.34%
|
Inhibrx Biosciences, Inc.
|
-5.12 USD
|
152.148%
|
Akebia Therapeutics, Inc.
|
-0.28 USD
|
1053.571%
|
Catalyst Pharmaceuticals, Inc.
|
0.67 USD
|
-298.507%
|
Longboard Pharmaceuticals, Inc.
|
-2.39 USD
|
211.715%
|
Orchestra BioMed Holdings, Inc.
|
-1.48 USD
|
280.405%
|
Alzamend Neuro, Inc.
|
-14.72 USD
|
118.139%
|
Sorrento Therapeutics, Inc.
|
-1.37 USD
|
294.891%
|
TRACON Pharmaceuticals, Inc.
|
-2.20 USD
|
221.364%
|
Viracta Therapeutics, Inc.
|
-1.32 USD
|
302.273%
|
Rocket Pharmaceuticals, Inc.
|
-2.92 USD
|
191.438%
|
Aptose Biosciences Inc.
|
-7.58 USD
|
135.224%
|
ZyVersa Therapeutics, Inc.
|
-1089.67 USD
|
100.245%
|
Soligenix, Inc.
|
-12.66 USD
|
121.09%
|
Century Therapeutics, Inc.
|
-2.30 USD
|
216.087%
|
Kura Oncology, Inc.
|
-2.08 USD
|
228.365%
|
TScan Therapeutics, Inc.
|
-1.36 USD
|
296.324%
|
Intensity Therapeutics, Inc.
|
-1.38 USD
|
293.478%
|
Ocean Biomedical, Inc.
|
-0.03 USD
|
10252.091%
|
CytomX Therapeutics, Inc.
|
-0.01 USD
|
34775.325%
|
Autolus Therapeutics plc
|
-1.20 USD
|
322.5%
|
Mineralys Therapeutics, Inc.
|
-1.99 USD
|
234.171%
|
EyePoint Pharmaceuticals, Inc.
|
-1.82 USD
|
246.703%
|
Eterna Therapeutics Inc.
|
-4.08 USD
|
165.441%
|
Adaptive Biotechnologies Corporation
|
-1.56 USD
|
271.154%
|
GRI Bio, Inc.
|
-28.25 USD
|
109.451%
|
Xenetic Biosciences, Inc.
|
-2.71 USD
|
198.524%
|
Tenaya Therapeutics, Inc.
|
-1.68 USD
|
258.929%
|
IGM Biosciences, Inc.
|
-4.71 USD
|
156.688%
|
INmune Bio, Inc.
|
-1.67 USD
|
259.88%
|
Heron Therapeutics, Inc.
|
-0.80 USD
|
433.75%
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
134.948%
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
121.107%
|
Entero Therapeutics, Inc.
|
-47.88 USD
|
105.576%
|
Milestone Pharmaceuticals Inc.
|
-1.39 USD
|
292.086%
|
X4 Pharmaceuticals, Inc.
|
-0.57 USD
|
568.421%
|
Atara Biotherapeutics, Inc.
|
-65.18 USD
|
104.096%
|
Coherus BioSciences, Inc.
|
-2.53 USD
|
205.534%
|
Verastem, Inc.
|
-3.96 USD
|
167.424%
|
Abeona Therapeutics Inc.
|
-2.53 USD
|
205.534%
|
Pliant Therapeutics, Inc.
|
-2.75 USD
|
197.091%
|
Tonix Pharmaceuticals Holding Corp.
|
-219.09 USD
|
101.219%
|
Histogen Inc.
|
-3.46 USD
|
177.168%
|
Aprea Therapeutics, Inc.
|
-3.95 USD
|
167.595%
|
Surrozen, Inc.
|
-21.33 USD
|
112.518%
|
Organovo Holdings, Inc.
|
-1.60 USD
|
266.875%
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
200.376%
|
Ovid Therapeutics Inc.
|
-0.74 USD
|
460.811%
|
Panbela Therapeutics, Inc.
|
-232.42 Thousand USD
|
100.001%
|
CASI Pharmaceuticals, Inc.
|
-2.02 USD
|
232.178%
|
Cadrenal Therapeutics, Inc. Common Stock
|
-0.62 USD
|
530.645%
|
Centessa Pharmaceuticals plc
|
-1.57 USD
|
270.064%
|
Hepion Pharmaceuticals, Inc.
|
-12.32 USD
|
121.672%
|
Arcturus Therapeutics Holdings Inc.
|
-1.12 USD
|
338.393%
|
BioRestorative Therapies, Inc.
|
-2.47 USD
|
208.097%
|
Apollomics, Inc.
|
-2.32 USD
|
215.086%
|
Amarin Corporation plc
|
-0.15 USD
|
1880.0%
|
Mesoblast Limited
|
-0.89 USD
|
400.0%
|
Turnstone Biologics Corp.
|
-4.77 USD
|
155.975%
|
Kymera Therapeutics, Inc.
|
-2.52 USD
|
205.952%
|
Synaptogenix, Inc.
|
-29.56 USD
|
109.032%
|
Tiziana Life Sciences Ltd
|
-0.16 USD
|
1768.75%
|
Aurinia Pharmaceuticals Inc.
|
-0.54 USD
|
594.444%
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
1020.69%
|
Monopar Therapeutics Inc.
|
-0.58 USD
|
560.345%
|
Exelixis, Inc.
|
0.65 USD
|
-310.769%
|
Better Therapeutics, Inc.
|
-1.69 USD
|
257.988%
|
Nurix Therapeutics, Inc.
|
-2.65 USD
|
200.755%
|
Apellis Pharmaceuticals, Inc.
|
-4.45 USD
|
160.0%
|
NLS Pharmaceutics AG
|
-0.32 USD
|
934.375%
|
Dermata Therapeutics, Inc.
|
-40.18 USD
|
106.645%
|
Aridis Pharmaceuticals, Inc.
|
-1.64 USD
|
262.805%
|
Gritstone bio, Inc.
|
-1.20 USD
|
322.5%
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
143.204%
|
TNF Pharmaceuticals, Inc.
|
-5.33 USD
|
150.094%
|
Avid Bioservices, Inc.
|
-2.23 USD
|
219.731%
|
Insmed Incorporated
|
-5.34 USD
|
150.0%
|
Virpax Pharmaceuticals, Inc.
|
-12.97 USD
|
120.586%
|
MediWound Ltd.
|
-0.75 USD
|
456.0%
|
OmniAb, Inc.
|
-0.51 USD
|
623.529%
|
Alector, Inc.
|
-1.56 USD
|
271.154%
|
Seres Therapeutics, Inc.
|
-0.89 USD
|
400.0%
|
Checkpoint Therapeutics, Inc.
|
-2.77 USD
|
196.39%
|
Zai Lab Limited
|
-3.46 USD
|
177.168%
|
Revance Therapeutics, Inc.
|
-3.83 USD
|
169.713%
|
Aura Biosciences, Inc.
|
-1.93 USD
|
238.342%
|
Lyell Immunopharma, Inc.
|
-0.93 USD
|
387.097%
|
Immunic, Inc.
|
-2.11 USD
|
226.54%
|
Tarsus Pharmaceuticals, Inc.
|
-4.62 USD
|
157.792%
|
Veracyte, Inc.
|
-1.02 USD
|
361.765%
|
InMed Pharmaceuticals Inc.
|
-1.01 USD
|
364.356%
|
FibroGen, Inc.
|
-2.92 USD
|
191.438%
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
108.815%
|
Adial Pharmaceuticals, Inc.
|
-5.44 USD
|
149.081%
|
Sonnet BioTherapeutics Holdings, Inc.
|
-18.14 USD
|
114.719%
|
Jazz Pharmaceuticals plc
|
6.95 USD
|
61.583%
|
Cyclacel Pharmaceuticals, Inc.
|
-26.75 USD
|
109.981%
|
Amylyx Pharmaceuticals, Inc.
|
0.73 USD
|
-265.753%
|
TG Therapeutics, Inc.
|
0.09 USD
|
-2889.922%
|
Galecto, Inc.
|
-36.08 USD
|
107.4%
|
Calithera Biosciences, Inc.
|
-7.94 USD
|
133.627%
|
Fortrea Holdings Inc.
|
-0.04 USD
|
7071.279%
|
KalVista Pharmaceuticals, Inc.
|
-3.44 USD
|
177.616%
|
Aptevo Therapeutics Inc.
|
-62.62 USD
|
104.264%
|
XBiotech Inc.
|
-0.81 USD
|
429.63%
|
Jasper Therapeutics, Inc.
|
-6.18 USD
|
143.204%
|
Lyra Therapeutics, Inc.
|
-1.26 USD
|
311.905%
|
Foghorn Therapeutics Inc.
|
-2.34 USD
|
214.103%
|
Y-mAbs Therapeutics, Inc.
|
-0.49 USD
|
644.898%
|
Theravance Biopharma, Inc.
|
-1.00 USD
|
367.0%
|
Ultragenyx Pharmaceutical Inc.
|
-8.25 USD
|
132.364%
|
Metagenomi, Inc. Common Stock
|
-1.82 USD
|
246.703%
|
Vaxxinity, Inc.
|
-0.45 USD
|
693.333%
|
BioCryst Pharmaceuticals, Inc.
|
-1.18 USD
|
326.271%
|
Gain Therapeutics, Inc.
|
-1.71 USD
|
256.14%
|
Cartesian Therapeutics, Inc.
|
-42.49 USD
|
106.284%
|
NexImmune, Inc.
|
-30.82 USD
|
108.663%
|
Creative Medical Technology Holdings, Inc.
|
-3.76 USD
|
171.011%
|
Marker Therapeutics, Inc.
|
-1.93 USD
|
238.342%
|
Regeneron Pharmaceuticals, Inc.
|
37.05 USD
|
92.794%
|
Chemomab Therapeutics Ltd.
|
-2.06 USD
|
229.612%
|
Scopus BioPharma Inc.
|
-0.55 USD
|
585.455%
|
RAPT Therapeutics, Inc.
|
-3.05 USD
|
187.541%
|
Ainos, Inc.
|
-3.36 USD
|
179.464%
|
Pluri Inc.
|
-3.99 USD
|
166.917%
|
Prothena Corporation plc
|
-2.76 USD
|
196.739%
|
Adaptimmune Therapeutics plc
|
-0.57 USD
|
568.421%
|
Celularity Inc.
|
-11.02 USD
|
124.229%
|
Rallybio Corporation
|
-1.84 USD
|
245.109%
|
Cue Biopharma, Inc.
|
-1.11 USD
|
340.541%
|
MeiraGTx Holdings plc
|
-1.49 USD
|
279.195%
|
Omeros Corporation
|
-1.88 USD
|
242.021%
|
Humacyte, Inc.
|
-1.07 USD
|
349.533%
|
Immunocore Holdings plc
|
-1.13 USD
|
336.283%
|
Cocrystal Pharma, Inc.
|
-1.86 USD
|
243.548%
|
Cidara Therapeutics, Inc.
|
-5.25 USD
|
150.857%
|
Blueprint Medicines Corporation
|
-8.37 USD
|
131.9%
|
CalciMedica, Inc.
|
-7.65 USD
|
134.902%
|
Cabaletta Bio, Inc.
|
-1.65 USD
|
261.818%
|
Marinus Pharmaceuticals, Inc.
|
-2.63 USD
|
201.521%
|
Scholar Rock Holding Corporation
|
-1.99 USD
|
234.171%
|
Sana Biotechnology, Inc.
|
-1.46 USD
|
282.877%
|
Pulmatrix, Inc.
|
-3.87 USD
|
168.992%
|
Elicio Therapeutics, Inc.
|
-6.96 USD
|
138.362%
|
Vigil Neuroscience, Inc.
|
-2.13 USD
|
225.352%
|
Intellia Therapeutics, Inc.
|
-5.42 USD
|
149.262%
|
Adlai Nortye Ltd. American Depositary Shares
|
-7.26 USD
|
136.777%
|
Cytokinetics, Incorporated
|
-5.45 USD
|
148.991%
|
Eloxx Pharmaceuticals, Inc.
|
-16.65 USD
|
116.036%
|
Nutriband Inc.
|
-0.69 USD
|
486.957%
|
Protara Therapeutics, Inc.
|
-3.57 USD
|
174.79%
|
Vor Biopharma Inc.
|
-1.75 USD
|
252.571%
|
Roivant Sciences Ltd.
|
5.55 USD
|
51.892%
|
Evogene Ltd.
|
-5.23 USD
|
151.052%
|
ProKidney Corp.
|
-0.57 USD
|
568.421%
|
Applied Therapeutics, Inc.
|
-1.42 USD
|
288.028%
|
Hoth Therapeutics, Inc.
|
-2.30 USD
|
216.087%
|
BridgeBio Pharma, Inc.
|
-3.95 USD
|
167.595%
|
CorMedix Inc.
|
-0.91 USD
|
393.407%
|
BioLineRx Ltd.
|
-0.94 USD
|
384.043%
|
Tango Therapeutics, Inc.
|
-1.08 USD
|
347.222%
|
Galectin Therapeutics Inc.
|
-0.74 USD
|
460.811%
|
Atai Life Sciences N.V.
|
-0.25 USD
|
1168.0%
|
Renovaro Biosciences Inc.
|
-0.84 USD
|
417.857%
|
Aerovate Therapeutics, Inc.
|
-2.87 USD
|
193.031%
|
Zentalis Pharmaceuticals, Inc.
|
-4.47 USD
|
159.732%
|
Sagimet Biosciences Inc.
|
-2.66 USD
|
200.376%
|
MediciNova, Inc.
|
-0.17 USD
|
1670.588%
|
Praxis Precision Medicines, Inc.
|
-18.69 USD
|
114.286%
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
504.545%
|
GeoVax Labs, Inc.
|
-10.22 USD
|
126.125%
|
Axsome Therapeutics, Inc.
|
-5.27 USD
|
150.664%
|
Biomea Fusion, Inc.
|
-3.44 USD
|
177.616%
|
PTC Therapeutics, Inc.
|
-8.37 USD
|
131.9%
|
Mereo BioPharma Group plc
|
-0.04 USD
|
6073.154%
|
Cullinan Oncology, Inc.
|
-3.69 USD
|
172.358%
|
Syndax Pharmaceuticals, Inc.
|
-2.98 USD
|
189.597%
|
Absci Corporation
|
-1.20 USD
|
322.5%
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
167.085%
|
4D Molecular Therapeutics, Inc.
|
-2.58 USD
|
203.488%
|
Dyne Therapeutics, Inc.
|
-3.95 USD
|
167.595%
|
Kiniksa Pharmaceuticals, Ltd.
|
0.20 USD
|
-1235.0%
|
Ventyx Biosciences, Inc.
|
-3.30 USD
|
180.909%
|
Allakos Inc.
|
-2.14 USD
|
224.766%
|
Imunon, Inc.
|
-2.16 USD
|
223.611%
|
Fulcrum Therapeutics, Inc.
|
-1.59 USD
|
267.925%
|
Corcept Therapeutics Incorporated
|
1.02 USD
|
-161.765%
|
BioAtla, Inc.
|
-2.58 USD
|
203.488%
|
NLS Pharmaceutics AG
|
-0.32 USD
|
934.375%
|
Bio-Path Holdings, Inc.
|
-33.64 USD
|
107.937%
|
Allogene Therapeutics, Inc.
|
-2.09 USD
|
227.751%
|
Larimar Therapeutics, Inc.
|
-0.84 USD
|
417.857%
|
XOMA Corporation
|
-4.04 USD
|
166.089%
|
Kezar Life Sciences, Inc.
|
-1.40 USD
|
290.714%
|
Cara Therapeutics, Inc.
|
-2.19 USD
|
221.918%
|
aTyr Pharma, Inc.
|
-0.94 USD
|
384.043%
|
Aligos Therapeutics, Inc.
|
-3.52 USD
|
175.852%
|
Akero Therapeutics, Inc.
|
-2.89 USD
|
192.388%
|
Viridian Therapeutics, Inc.
|
-5.31 USD
|
150.282%
|
Eliem Therapeutics, Inc.
|
-1.30 USD
|
305.385%
|
EyeGate Pharmaceuticals, Inc.
|
-2.54 USD
|
205.118%
|
Akari Therapeutics, Plc
|
-2.04 USD
|
230.882%
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
667600.0%
|
Halozyme Therapeutics, Inc.
|
2.13 USD
|
-25.352%
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
364.356%
|
UroGen Pharma Ltd.
|
-3.55 USD
|
175.211%
|
Sutro Biopharma, Inc.
|
-1.78 USD
|
250.0%
|
ZIVO Bioscience, Inc.
|
-4.60 USD
|
158.043%
|
Orgenesis Inc.
|
-1.91 USD
|
239.791%
|
Entera Bio Ltd.
|
-0.31 USD
|
961.29%
|
GH Research PLC
|
-0.68 USD
|
492.647%
|
Lisata Therapeutics, Inc.
|
-2.58 USD
|
203.488%
|
Reneo Pharmaceuticals, Inc.
|
-25.23 USD
|
110.583%
|
Xencor, Inc.
|
-2.08 USD
|
228.365%
|
60 Degrees Pharmaceuticals, Inc.
|
-0.95 USD
|
381.053%
|
Replimune Group, Inc.
|
-3.24 USD
|
182.407%
|
Coeptis Therapeutics Holdings, Inc.
|
-0.83 USD
|
421.687%
|
Vanda Pharmaceuticals Inc.
|
0.04 USD
|
-6009.84%
|
Lexaria Bioscience Corp.
|
-1.01 USD
|
364.356%
|
Portage Biotech Inc.
|
-3.70 USD
|
172.162%
|
Cardio Diagnostics Holdings, Inc.
|
-0.66 USD
|
504.545%
|
Olema Pharmaceuticals, Inc.
|
-2.14 USD
|
224.766%
|
OncoCyte Corporation
|
-3.75 USD
|
171.2%
|
Qualigen Therapeutics, Inc.
|
-2.46 USD
|
208.537%
|
Processa Pharmaceuticals, Inc.
|
-8.48 USD
|
131.486%
|
Purple Biotech Ltd.
|
-0.09 USD
|
3073.274%
|
CollPlant Biotechnologies Ltd.
|
-0.62 USD
|
530.645%
|
scPharmaceuticals Inc.
|
-1.42 USD
|
288.028%
|
ProMIS Neurosciences, Inc.
|
-1.42 USD
|
288.028%
|
HilleVax, Inc.
|
-3.04 USD
|
187.829%
|
NeuroSense Therapeutics Ltd.
|
-0.83 USD
|
421.687%
|
Tharimmune, Inc.
|
-107.08 USD
|
102.493%
|
Genprex, Inc.
|
-22.58 USD
|
111.825%
|
Neumora Therapeutics, Inc. Common Stock
|
-1.49 USD
|
279.195%
|
Atossa Therapeutics, Inc.
|
-0.24 USD
|
1212.5%
|
XTL Biopharmaceuticals Ltd.
|
-0.00 USD
|
81009.091%
|
Virios Therapeutics, Inc.
|
-0.28 USD
|
1053.571%
|
OKYO Pharma Limited
|
-0.00 USD
|
445100.0%
|
Savara Inc.
|
-0.33 USD
|
909.091%
|
Curis, Inc.
|
-8.96 USD
|
129.799%
|
Daré Bioscience, Inc.
|
-4.15 USD
|
164.337%
|
Carmell Therapeutics Corporation
|
-1.46 USD
|
282.877%
|
Titan Pharmaceuticals, Inc.
|
-7.41 USD
|
136.032%
|
Achieve Life Sciences, Inc.
|
-1.50 USD
|
278.0%
|
BeiGene, Ltd.
|
-8.45 USD
|
131.598%
|
Kiromic BioPharma, Inc.
|
-21.41 USD
|
112.471%
|
Revolution Medicines, Inc. Warrant
|
-3.86 USD
|
169.171%
|
Protagonist Therapeutics, Inc.
|
-1.39 USD
|
292.086%
|
Erasca, Inc.
|
-0.83 USD
|
421.687%
|
bluebird bio, Inc.
|
-1.93 USD
|
238.342%
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
332.174%
|
BioMarin Pharmaceutical Inc.
|
0.89 USD
|
-200.0%
|
DBV Technologies S.A.
|
-0.76 USD
|
451.316%
|
Protagenic Therapeutics, Inc.
|
-1.15 USD
|
332.174%
|
Moderna, Inc.
|
-12.34 USD
|
121.637%
|
Vincerx Pharma, Inc.
|
-1.89 USD
|
241.27%
|
Fresh Tracks Therapeutics, Inc.
|
-0.96 USD
|
378.125%
|
Molecular Templates, Inc.
|
-1.80 USD
|
248.333%
|
Acrivon Therapeutics, Inc. Common Stock
|
-2.74 USD
|
197.445%
|
Travere Therapeutics, Inc.
|
-1.50 USD
|
278.0%
|
Monte Rosa Therapeutics, Inc.
|
-2.63 USD
|
201.521%
|
Spruce Biosciences, Inc.
|
-1.24 USD
|
315.323%
|
Celldex Therapeutics, Inc.
|
-2.92 USD
|
191.438%
|
Cogent Biosciences, Inc.
|
-2.42 USD
|
210.331%
|
MacroGenics, Inc.
|
-0.15 USD
|
1880.0%
|
RenovoRx, Inc.
|
-0.99 USD
|
369.697%
|
Adicet Bio, Inc.
|
-3.31 USD
|
180.665%
|
Prime Medicine, Inc.
|
-2.18 USD
|
222.477%
|
Aditxt, Inc.
|
-4326.64 USD
|
100.062%
|
Adagene Inc.
|
-0.44 USD
|
706.818%
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
1371.429%
|
Quantum-Si incorporated
|
-0.68 USD
|
492.647%
|
Maravai LifeSciences Holdings, Inc.
|
-0.90 USD
|
396.667%
|
Acurx Pharmaceuticals, Inc.
|
-1.15 USD
|
332.174%
|
Voyager Therapeutics, Inc.
|
3.08 USD
|
13.312%
|
SciSparc Ltd.
|
-14.43 USD
|
118.503%
|
Vericel Corporation
|
-0.07 USD
|
4091.031%
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
603.774%
|
Minerva Neurosciences, Inc.
|
-4.61 USD
|
157.918%
|
Generation Bio Co.
|
-1.96 USD
|
236.224%
|
Astria Therapeutics, Inc.
|
-2.42 USD
|
210.331%
|
Black Diamond Therapeutics, Inc.
|
-1.88 USD
|
242.021%
|
Arcutis Biotherapeutics, Inc.
|
-3.78 USD
|
170.635%
|
Invivyd, Inc.
|
-1.81 USD
|
247.514%
|
Relay Therapeutics, Inc.
|
-2.79 USD
|
195.699%
|
Quoin Pharmaceuticals, Ltd.
|
-9.64 USD
|
127.697%
|
Spero Therapeutics, Inc.
|
0.43 USD
|
-520.93%
|
Artelo Biosciences, Inc.
|
-3.49 USD
|
176.504%
|
2seventy bio, Inc.
|
-4.42 USD
|
160.407%
|
ADMA Biologics, Inc.
|
-0.13 USD
|
2153.846%
|
Clene Inc.
|
-9.43 USD
|
128.314%
|
Capricor Therapeutics, Inc.
|
-0.83 USD
|
421.687%
|
Boundless Bio, Inc. Common Stock
|
-2.22 USD
|
220.27%
|
GeoVax Labs, Inc.
|
-10.22 USD
|
126.125%
|
Recursion Pharmaceuticals, Inc.
|
-1.58 USD
|
268.987%
|
Citius Pharmaceuticals, Inc.
|
-0.22 USD
|
1313.636%
|
Contineum Therapeutics, Inc. Class A Common Stock
|
1.36 USD
|
-96.324%
|
Relmada Therapeutics, Inc.
|
-3.28 USD
|
181.402%
|
Finch Therapeutics Group, Inc.
|
-46.59 USD
|
105.731%
|
ALX Oncology Holdings Inc.
|
-3.74 USD
|
171.39%
|
Vir Biotechnology, Inc.
|
-4.59 USD
|
158.17%
|
Evaxion Biotech A/S
|
-8.11 USD
|
132.922%
|
Ocular Therapeutix, Inc.
|
-1.09 USD
|
344.954%
|
Verve Therapeutics, Inc.
|
-3.12 USD
|
185.577%
|
Trevena, Inc.
|
-54.51 USD
|
104.898%
|
Surrozen, Inc.
|
-21.33 USD
|
112.518%
|
Tyra Biosciences, Inc.
|
-1.62 USD
|
264.815%
|
Cingulate Inc.
|
-311.99 USD
|
100.856%
|
Galmed Pharmaceuticals Ltd.
|
-30.05 USD
|
108.885%
|
Unity Biotechnology, Inc.
|
-2.70 USD
|
198.889%
|
Tenax Therapeutics, Inc.
|
-31.09 USD
|
108.588%
|
Terns Pharmaceuticals, Inc.
|
-1.27 USD
|
310.236%
|
ACADIA Pharmaceuticals Inc.
|
-0.37 USD
|
821.622%
|
Connect Biopharma Holdings Limited
|
-1.08 USD
|
347.222%
|
Clearmind Medicine Inc.
|
-59.18 USD
|
104.512%
|
Kronos Bio, Inc.
|
-1.95 USD
|
236.923%
|
Bolt Biotherapeutics, Inc.
|
-1.83 USD
|
245.902%
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
784.615%
|
Viking Therapeutics, Inc.
|
-0.91 USD
|
393.407%
|
Statera Biopharma, Inc.
|
-4.97 USD
|
153.722%
|
ImmunityBio, Inc.
|
-1.15 USD
|
332.174%
|
Korro Bio, Inc.
|
-53.08 USD
|
105.03%
|
Kineta, Inc.
|
-1.28 USD
|
308.594%
|
BioVie Inc.
|
-7.30 USD
|
136.575%
|
Codexis, Inc.
|
-1.12 USD
|
338.393%
|
Celularity Inc.
|
-11.02 USD
|
124.229%
|
Crinetics Pharmaceuticals, Inc.
|
-3.69 USD
|
172.358%
|
Celcuity Inc.
|
-2.69 USD
|
199.257%
|
Virax Biolabs Group Limited
|
-3.36 USD
|
179.464%
|
Cibus, Inc.
|
-25.95 USD
|
110.289%
|
Eledon Pharmaceuticals, Inc.
|
-0.00 USD
|
166975.0%
|
eFFECTOR Therapeutics, Inc.
|
-16.37 USD
|
116.31%
|
IN8bio, Inc.
|
-1.00 USD
|
367.0%
|
Kodiak Sciences Inc.
|
-4.97 USD
|
153.722%
|
Annexon, Inc.
|
-1.77 USD
|
250.847%
|
Adverum Biotechnologies, Inc.
|
-11.62 USD
|
122.978%
|
Assembly Biosciences, Inc.
|
-13.38 USD
|
119.955%
|
Avalo Therapeutics, Inc.
|
-113.58 USD
|
102.351%
|
Ionis Pharmaceuticals, Inc.
|
-2.56 USD
|
204.297%
|
Eyenovia, Inc.
|
-0.66 USD
|
504.545%
|
Puma Biotechnology, Inc.
|
0.46 USD
|
-480.435%
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
3053.54%
|
Xilio Therapeutics, Inc.
|
-2.78 USD
|
196.043%
|
Arcellx, Inc.
|
-1.47 USD
|
281.633%
|
Cardiff Oncology, Inc.
|
-0.93 USD
|
387.097%
|
Enanta Pharmaceuticals, Inc.
|
-6.38 USD
|
141.85%
|
Regulus Therapeutics Inc.
|
-1.58 USD
|
268.987%
|
Moolec Science SA
|
-1.50 USD
|
278.0%
|
Acumen Pharmaceuticals, Inc.
|
-1.08 USD
|
347.222%
|
Geron Corporation
|
-0.32 USD
|
934.375%
|
LAVA Therapeutics N.V.
|
-1.57 USD
|
270.064%
|
Royalty Pharma plc
|
3.41 USD
|
21.701%
|
Atea Pharmaceuticals, Inc.
|
-1.63 USD
|
263.804%
|
Greenwich LifeSciences, Inc.
|
-0.69 USD
|
486.957%
|
TFF Pharmaceuticals, Inc.
|
-11.85 USD
|
122.532%
|
Mersana Therapeutics, Inc.
|
-1.48 USD
|
280.405%
|
Humacyte, Inc.
|
-1.07 USD
|
349.533%
|
Structure Therapeutics Inc.
|
-2.44 USD
|
209.426%
|
89bio, Inc.
|
-2.00 USD
|
233.5%
|
PMV Pharmaceuticals, Inc.
|
-1.44 USD
|
285.417%
|
Avenue Therapeutics, Inc.
|
-73.60 USD
|
103.628%
|
Genelux Corporation
|
-1.16 USD
|
330.172%
|
Trevi Therapeutics, Inc.
|
-0.29 USD
|
1020.69%
|
Lexicon Pharmaceuticals, Inc.
|
-0.80 USD
|
433.75%
|
Notable Labs, Ltd.
|
-5.03 USD
|
153.082%
|
Liquidia Corporation
|
-1.21 USD
|
320.661%
|
Mustang Bio, Inc.
|
-6.00 USD
|
144.5%
|
Immunovant, Inc.
|
-1.88 USD
|
242.021%
|
Quantum-Si incorporated
|
-0.68 USD
|
492.647%
|
Arbutus Biopharma Corporation
|
-0.44 USD
|
706.818%
|
DiaMedica Therapeutics Inc.
|
-0.60 USD
|
545.0%
|
Vera Therapeutics, Inc.
|
-2.25 USD
|
218.667%
|
Acasti Pharma Inc.
|
-1.35 USD
|
297.778%
|
MiNK Therapeutics, Inc.
|
-0.65 USD
|
510.769%
|
Pasithea Therapeutics Corp.
|
-12.65 USD
|
121.107%
|
Xenon Pharmaceuticals Inc.
|
-2.73 USD
|
197.802%
|
Elevai Labs, Inc. Common Stock
|
-0.40 USD
|
767.5%
|
NeuroBo Pharmaceuticals, Inc.
|
-2.46 USD
|
208.537%
|
Tempest Therapeutics, Inc.
|
-1.91 USD
|
239.791%
|
Soleno Therapeutics, Inc.
|
-2.36 USD
|
213.136%
|
PepGen Inc.
|
-3.30 USD
|
180.909%
|
Moleculin Biotech, Inc.
|
-15.07 USD
|
117.717%
|
United Therapeutics Corporation
|
21.04 USD
|
87.31%
|
Nuvectis Pharma, Inc.
|
-1.43 USD
|
286.713%
|
Solid Biosciences Inc.
|
-4.83 USD
|
155.28%
|
BriaCell Therapeutics Corp.
|
-0.29 USD
|
1020.69%
|
Immuneering Corporation
|
-1.88 USD
|
242.021%
|
Lixte Biotechnology Holdings, Inc.
|
-2.66 USD
|
200.376%
|
Silo Pharma, Inc.
|
-1.20 USD
|
322.5%
|
Belite Bio, Inc
|
-1.19 USD
|
324.37%
|
XOMA Corporation
|
-4.04 USD
|
166.089%
|
ARS Pharmaceuticals, Inc.
|
-0.57 USD
|
568.421%
|
Bionomics Limited
|
-1.02 USD
|
361.765%
|
Apogee Therapeutics, Inc.
|
-0.00 USD
|
78629.412%
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
735.714%
|
uniQure N.V.
|
-6.47 USD
|
141.267%
|
Cassava Sciences, Inc.
|
-2.32 USD
|
215.086%
|
Estrella Immunopharma, Inc.
|
-0.21 USD
|
1371.429%
|
Poseida Therapeutics, Inc.
|
-1.37 USD
|
294.891%
|
Forte Biosciences, Inc.
|
-24.92 USD
|
110.714%
|
Anebulo Pharmaceuticals, Inc.
|
-0.32 USD
|
934.375%
|
Enlivex Therapeutics Ltd.
|
-1.56 USD
|
271.154%
|
Conduit Pharmaceuticals Inc.
|
-0.09 USD
|
3053.54%
|
SeaStar Medical Holding Corporation
|
-30.29 USD
|
108.815%
|
FibroBiologics, Inc. Common Stock
|
-0.59 USD
|
552.542%
|
Altimmune, Inc.
|
-1.66 USD
|
260.843%
|
Amicus Therapeutics, Inc.
|
-0.51 USD
|
623.529%
|
Alpha Tau Medical Ltd.
|
-0.42 USD
|
735.714%
|
Compugen Ltd.
|
-0.21 USD
|
1371.429%
|
Peak Bio, Inc.
|
- USD
|
-Infinity%
|
Zevra Therapeutics, Inc.
|
-1.30 USD
|
305.385%
|
Benitec Biopharma Inc.
|
-5.36 USD
|
149.813%
|
Spyre Therapeutics, Inc.
|
-49.12 USD
|
105.436%
|
NKGen Biotech, Inc. Common Stock
|
-5.38 USD
|
149.628%
|
Zura Bio Limited
|
-2.09 USD
|
227.751%
|
PolyPid Ltd.
|
-16.99 USD
|
115.715%
|
Aileron Therapeutics, Inc.
|
-3.42 USD
|
178.07%
|
NKGen Biotech, Inc. Warrants
|
-5.38 USD
|
149.628%
|
Instil Bio, Inc.
|
-24.00 USD
|
111.125%
|
argenx SE
|
-5.16 USD
|
151.744%
|
Immunome, Inc.
|
-5.38 USD
|
149.628%
|
Compass Therapeutics, Inc.
|
-0.33 USD
|
909.091%
|
Verona Pharma plc
|
-0.54 USD
|
594.444%
|
enGene Holdings Inc. Warrants
|
-4.51 USD
|
159.202%
|
Shattuck Labs, Inc.
|
-2.05 USD
|
230.244%
|
CervoMed Inc.
|
-0.82 USD
|
425.61%
|
LENZ Therapeutics, Inc.
|
-15.30 USD
|
117.451%
|
Plus Therapeutics, Inc.
|
-4.24 USD
|
162.972%
|
Dianthus Therapeutics, Inc.
|
-8.45 USD
|
131.598%
|
Moolec Science SA
|
-1.50 USD
|
278.0%
|
Enveric Biosciences, Inc.
|
-8.09 USD
|
133.004%
|
Inovio Pharmaceuticals, Inc.
|
-6.09 USD
|
143.842%
|
AnaptysBio, Inc.
|
-6.08 USD
|
143.914%
|
Design Therapeutics, Inc.
|
-1.19 USD
|
324.37%
|
Leap Therapeutics, Inc.
|
-3.98 USD
|
167.085%
|
NeurAxis, Inc.
|
-4.03 USD
|
166.253%
|
Seelos Therapeutics, Inc.
|
-7.73 USD
|
134.541%
|
Lumos Pharma, Inc.
|
-4.18 USD
|
163.876%
|
Achilles Therapeutics plc
|
-1.74 USD
|
253.448%
|
enGene Holdings Inc. Common Stock
|
-4.51 USD
|
159.202%
|
180 Life Sciences Corp.
|
-52.60 USD
|
105.076%
|
Opiant Pharmaceuticals, Inc.
|
0.68 USD
|
-292.647%
|
CERo Therapeutics Holdings, Inc.
|
-0.39 USD
|
784.615%
|
Nutriband Inc.
|
-0.69 USD
|
486.957%
|
ORIC Pharmaceuticals, Inc.
|
-1.96 USD
|
236.224%
|
CG Oncology, Inc. Common stock
|
-15.65 USD
|
117.061%
|
Fractyl Health, Inc. Common Stock
|
-1.98 USD
|
234.848%
|
Rani Therapeutics Holdings, Inc.
|
-1.33 USD
|
300.752%
|
MoonLake Immunotherapeutics
|
-0.73 USD
|
465.753%
|
Palisade Bio, Inc.
|
-27.01 USD
|
109.885%
|
Tourmaline Bio, Inc.
|
-8.87 USD
|
130.101%
|
Beam Therapeutics Inc.
|
-1.72 USD
|
255.233%
|
Neurogene Inc.
|
-2.83 USD
|
194.346%
|
Mirum Pharmaceuticals, Inc.
|
-4.00 USD
|
166.75%
|
AEON Biopharma, Inc.
|
- USD
|
-Infinity%
|
CARGO Therapeutics, Inc. Common Stock
|
-2.38 USD
|
212.185%
|
Sesen Bio, Inc.
|
-1.99 USD
|
234.171%
|
Enliven Therapeutics, Inc.
|
-2.01 USD
|
232.836%
|
Kiora Pharmaceuticals, Inc.
|
-24.25 USD
|
111.01%
|
Iovance Biotherapeutics, Inc.
|
-1.89 USD
|
241.27%
|
Taysha Gene Therapies, Inc.
|
-0.96 USD
|
378.125%
|
Athira Pharma, Inc.
|
-3.10 USD
|
186.129%
|
Vaccinex, Inc.
|
-43.68 USD
|
106.113%
|
HCW Biologics Inc.
|
-0.70 USD
|
481.429%
|
XOMA Corporation
|
-4.04 USD
|
166.089%
|
Nektar Therapeutics
|
-1.45 USD
|
284.138%
|
Arvinas, Inc.
|
-6.62 USD
|
140.332%
|
Tevogen Bio Holdings Inc.
|
-0.00 USD
|
667600.0%
|
Merus N.V.
|
-3.00 USD
|
189.0%
|
Omega Therapeutics, Inc.
|
-1.80 USD
|
248.333%
|
Quince Therapeutics, Inc.
|
-0.84 USD
|
417.857%
|
Rezolute, Inc.
|
-1.33 USD
|
300.752%
|
Clene Inc.
|
-9.43 USD
|
128.314%
|
Indaptus Therapeutics, Inc.
|
-1.84 USD
|
245.109%
|
BeyondSpring Inc.
|
-0.54 USD
|
594.444%
|
Synlogic, Inc.
|
-8.81 USD
|
130.306%
|
Allarity Therapeutics, Inc.
|
-0.01 USD
|
26022.33%
|
Phio Pharmaceuticals Corp.
|
-46.87 USD
|
105.697%
|
Peak Bio, Inc.
|
- USD
|
-Infinity%
|
Werewolf Therapeutics, Inc.
|
-1.05 USD
|
354.286%
|
Krystal Biotech, Inc.
|
0.40 USD
|
-567.5%
|
Karyopharm Therapeutics Inc.
|
-1.25 USD
|
313.6%
|
SpringWorks Therapeutics, Inc.
|
-5.15 USD
|
151.845%
|
Lipella Pharmaceuticals Inc.
|
-0.77 USD
|
446.753%
|
MannKind Corporation
|
-0.04 USD
|
6073.154%
|
Ikena Oncology, Inc.
|
-1.63 USD
|
263.804%
|
Cyclerion Therapeutics, Inc.
|
-8.99 USD
|
129.7%
|
Gyre Therapeutics, Inc.
|
-1.41 USD
|
289.362%
|
Gossamer Bio, Inc.
|
-1.18 USD
|
326.271%
|
CohBar, Inc.
|
-4.13 USD
|
164.649%
|
Cognition Therapeutics, Inc.
|
-0.86 USD
|
410.465%
|
NRx Pharmaceuticals, Inc.
|
-3.98 USD
|
167.085%
|
Legend Biotech Corporation
|
-2.94 USD
|
190.816%
|
Mural Oncology plc
|
-12.43 USD
|
121.48%
|
Biora Therapeutics, Inc.
|
-7.87 USD
|
133.926%
|
PaxMedica, Inc. Common Stock
|
-11.00 USD
|
124.273%
|
Disc Medicine, Inc.
|
-3.43 USD
|
177.843%
|
Champions Oncology, Inc.
|
-0.54 USD
|
594.444%
|
REGENXBIO Inc.
|
-6.02 USD
|
144.352%
|
Ensysce Biosciences, Inc.
|
-4.69 USD
|
156.93%
|
Anavex Life Sciences Corp.
|
-0.60 USD
|
545.0%
|
Cellectar Biosciences, Inc.
|
-3.11 USD
|
185.852%
|
Edgewise Therapeutics, Inc.
|
-1.57 USD
|
270.064%
|
Vaxart, Inc.
|
-0.57 USD
|
568.421%
|
PharmaCyte Biotech, Inc.
|
-1.80 USD
|
248.333%
|
Aldeyra Therapeutics, Inc.
|
-0.64 USD
|
517.188%
|
Cellectis S.A.
|
-1.77 USD
|
250.847%
|
Longeveron Inc.
|
-10.22 USD
|
126.125%
|
Repare Therapeutics Inc.
|
-2.23 USD
|
219.731%
|
Sarepta Therapeutics, Inc.
|
-5.80 USD
|
146.034%
|
Inozyme Pharma, Inc.
|
-1.37 USD
|
294.891%
|
Revolution Medicines, Inc.
|
-3.86 USD
|
169.171%
|
Nymox Pharmaceutical Corporation
|
-0.07 USD
|
3732.653%
|
Third Harmonic Bio, Inc.
|
-0.78 USD
|
442.308%
|
ArriVent BioPharma, Inc. Common Stock
|
-2.17 USD
|
223.041%
|
AN2 Therapeutics, Inc.
|
-2.74 USD
|
197.445%
|
Anixa Biosciences, Inc.
|
-0.32 USD
|
934.375%
|
Vertex Pharmaceuticals Incorporated
|
14.05 USD
|
80.996%
|
Denali Therapeutics Inc.
|
-1.06 USD
|
351.887%
|
Revelation Biosciences, Inc.
|
-0.53 USD
|
603.774%
|
Veru Inc.
|
-1.10 USD
|
342.727%
|
Corvus Pharmaceuticals, Inc.
|
-0.56 USD
|
576.786%
|
Cingulate Inc.
|
-311.99 USD
|
100.856%
|
Passage Bio, Inc.
|
-1.86 USD
|
243.548%
|
Context Therapeutics Inc.
|
-1.50 USD
|
278.0%
|
Exicure, Inc.
|
-2.11 USD
|
226.54%
|
Day One Biopharmaceuticals, Inc.
|
-2.37 USD
|
212.658%
|
Oramed Pharmaceuticals Inc.
|
-0.97 USD
|
375.258%
|
Scinai Immunotherapeutics Ltd.
|
-16.62 USD
|
116.065%
|
Rhythm Pharmaceuticals, Inc.
|
-3.20 USD
|
183.438%
|
Nuvalent, Inc.
|
-2.17 USD
|
223.041%
|
ABVC BioPharma, Inc.
|
-2.43 USD
|
209.877%
|
Carisma Therapeutics, Inc.
|
-2.59 USD
|
203.089%
|
Unicycive Therapeutics, Inc.
|
-1.28 USD
|
308.594%
|
OmniAb, Inc.
|
-0.51 USD
|
623.529%
|
Anew Medical, Inc.
|
0.14 USD
|
-1807.143%
|
Fennec Pharmaceuticals Inc.
|
-0.60 USD
|
545.0%
|
Lipocine Inc.
|
-3.14 USD
|
185.032%
|
Lexeo Therapeutics, Inc. Common Stock
|
-2.49 USD
|
207.229%
|
Nautilus Biotechnology, Inc.
|
-0.51 USD
|
623.529%
|
SAB Biotherapeutics, Inc.
|
-7.64 USD
|
134.948%
|
G1 Therapeutics, Inc.
|
-0.93 USD
|
387.097%
|
Bellerophon Therapeutics, Inc.
|
-2.08 USD
|
228.365%
|
Sage Therapeutics, Inc.
|
-9.05 USD
|
129.503%
|
Ocugen, Inc.
|
-0.26 USD
|
1126.923%
|
Mind Medicine (MindMed) Inc.
|
-2.44 USD
|
209.426%
|
Q32 Bio Inc.
|
-35.16 USD
|
107.594%
|
Brainstorm Cell Therapeutics Inc.
|
-0.40 USD
|
767.5%
|
Alumis Inc. Common Stock
|
-2.99 USD
|
189.298%
|
Equillium, Inc.
|
-0.38 USD
|
802.632%
|
Kyverna Therapeutics, Inc.
|
-0.00 USD
|
2670100.0%
|
Coya Therapeutics, Inc.
|
-0.79 USD
|
437.975%
|
CNS Pharmaceuticals, Inc.
|
-251.35 USD
|
101.062%
|
Galera Therapeutics, Inc.
|
-1.33 USD
|
300.752%
|
Evelo Biosciences, Inc.
|
-26.28 USD
|
110.16%
|
Comera Life Sciences Holdings, Inc.
|
-1.76 USD
|
251.705%
|
Dominari Holdings Inc.
|
-4.38 USD
|
160.959%
|
Edesa Biotech, Inc.
|
-2.93 USD
|
191.126%
|
vTv Therapeutics Inc.
|
-9.71 USD
|
127.497%
|
Bio-Techne Corporation
|
1.07 USD
|
-149.533%
|
Agios Pharmaceuticals, Inc.
|
-6.33 USD
|
142.18%
|
Harmony Biosciences Holdings, Inc.
|
2.17 USD
|
-23.041%
|
Prelude Therapeutics Incorporated
|
-2.02 USD
|
232.178%
|
Candel Therapeutics, Inc.
|
-1.31 USD
|
303.817%
|
iTeos Therapeutics, Inc.
|
-3.15 USD
|
184.762%
|
Nkarta, Inc.
|
-2.40 USD
|
211.25%
|
BioCardia, Inc.
|
-8.19 USD
|
132.601%
|
Iterum Therapeutics plc
|
-2.96 USD
|
190.203%
|